// App-Quantinova.ai

214 : Case Presentation: PRES in the Setting of Goodpasture Disease Treated With Cyclophosphamide

Researchers

Presenter

  • Mala Joneja

Principal Investigators

  • Gordon Boyd

  • Michael Beyak

Medical Centers

  • Queens University, Kingston, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Urology

Disease

  • Posterior Reversible Encephalopathy Syndrome

  • Rapidly progressive glomerulonephritis

  • Vasodilation dysfunction

  • Acute renal failure

  • Pulmonary embolism

  • Glomerulonephritis

  • Encephalopathy

  • Coronary Artery Disease

  • Acute lung injury

Biomarkers

  • Immunoglobulin G

  • Interferon

Drug/Treatment

  • Methylprednisolone

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Cyclosporine eent

  • Bevacizumab

  • Tacrolimus

  • Interferon

  • Cisplatin

  • Rapacan

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved